Author

Nancy Sein

Observed name: N. Sein

Observed institutions: Brooke Army Medical Center, University of California, San Francisco, Yangon University of Foreign Languages, UCSF Helen Diller Family Comprehensive Cancer Center

OpenAlex ID: A5076085259

von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma

2008 · Toni K. Choueiri, Susan A.J. Vaziri, et al. · The Journal of Urology · 203

Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel‐Lindau gene status

2006 · Brian I. Rini, Erich Jaeger, et al. · British Journal of Urology · 110

Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer

2006 · Karolin Trautmann, Jonathan P. Terdiman, et al. · Clinical Cancer Research · 107

New agents in renal cell carcinoma

2013 · Raetasha Dabney, Ryan Devine, et al. · Targeted Oncology · 30

Data from Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer

2023 · Karolin Trautmann, Jonathan P. Terdiman, et al.

Data from Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer

2023 · Karolin Trautmann, Jonathan P. Terdiman, et al.

Primary aCGH data and supplementary tables from Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer

2023 · Karolin Trautmann, Jonathan P. Terdiman, et al.

Primary aCGH data and supplementary tables from Chromosomal Instability in Microsatellite-Unstable and Stable Colon Cancer

2023 · Karolin Trautmann, Jonathan P. Terdiman, et al.

Clinical outcome of treatment without trastuzumab in HER2 positive breast cancer patients

2019 · T.T. Aye, S. Mon, et al. · Annals of Oncology

Myanmar clinicians' preference of truth telling about cancer diagnosis

2017 · S. Mon, T.T. Aye, et al. · Annals of Oncology

86P Overview of breast cancer management: Yangon private sector cancer care

2016 · S. Mon, T.T. Aye, et al. · Annals of Oncology

79P Molecular targeted therapy for Her2 positive breast cancer in private sector: Yangon experience

2016 · M. Khine, S. Mon, et al. · Annals of Oncology

Works count: 13

Citation count: 450

H-index: 4

I10-index: 4